Solid Biosciences (SLDB) Long-Term Debt Repayments (2024 - 2025)
Solid Biosciences (SLDB) reported Long-Term Debt Repayments of $203000.0 for Q4 2025, up 58.59% on a YoY basis from $128000.0 in Q4 2024, and down 16.46% sequentially from $243000.0 in Q3 2025.
Solid Biosciences (SLDB) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends
Solid Biosciences (SLDB) has 2 years of Long-Term Debt Repayments data on file, last reported at $203000.0 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Debt Repayments rose 58.59% year-over-year to $203000.0; the trailing twelve-month figure through Mar 2026 stood at $588000.0 (down 3.29% YoY), and the FY2025 full-year result was $723000.0, up 52.85% from the prior year.
- Long-Term Debt Repayments eased to $203000.0 in Q4 2025, from $243000.0 in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $243000.0 in Q3 2025 to a low of $120000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.64 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 203,000.00 |
| Dec 31, 2025 | 203,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 225,000.00 |
| Jun 30, 2024 | 225,000.00 |